Member Info for TR64

Only boring when its pointed out the UK will keep people in there 70'80's in ICU on Ventilators for covid 19 costing 100 more than it costs to treat a 1 woman with Zejula

DMP

That incorrect, the UK NICE refused to allow BLENREP ., stating costs as the reason the same with Zejula.
No point in having ground breaking treatments that can be used in the EU, but not in the UK.

two of the Oncology Drugs brought to market, both the Uk would not use.Great Science is not alloweed to be used in the UK, and that is factual

TA.
Perhaps the FT can explain its reporting and EW.
Zejula was only sanctioned by NICE National Institute for Clinical In excellence for use on January 20 2021
It was approved by the EU on October 30th

Perhaps it would be wise if EW and the FT asked Han**** why the UK refused to sanction its use, of course the answer as been it cost to much, but the EU had no issue.

Again this demonstrates how bad the UK is in Cancer Treatment, its the worse in the western World. Embarrassing that 7000 UK women were denied access to this treatment while the EU sanctioned it 3 months earlier

Is this not reported by that rag the FT, the FT never reports the key facts.

Interested to hear the w8anker at the FT or Credit Suisse comments

CVAC is the answer expect results in under 1 month, if you hold CVAC you are going to be happy, it's the German superior vaccine , that as not needed a Pfizer or such to get where it is.

VIR GSK have made over $1.9 billion on so far, expect VIR to go another 230% up by End of April

From experience
Put 2000 shares on sell @£1525 and 15000 shares on sell price of £1700

The market is rigged but if you actually list all your shares for sale at £1525 and above, it does make it harder and stops the panic that ensues .

Be interested to see Rolls Royce forecast going forward, based on today, then Rolls Royce is not worth 5 pence, its debts are more than GSK turnover

List of EU countries restricting AstraZeneca COVID-19 vaccine grows

France, Germany, Belgium, Italy, Sweden, Austria and Poland have all restricted the Oxford University-AstraZeneca vaccine in older groups this week, despite the European Medicines Agency recommending it for adults of all ages.

taly and Belgium limiting its use to the under-55s. Belgian Health Minister Frank Vandenbroucke told reporters on Tuesday: "We don't have enough information to be sure to say that it is good for the elderly."

Italy's medicines agency AIFA has recommended "preferential use of the AstraZeneca vaccine, pending further data, in subjects between 18 and 55 years old, for whom more solid evidence is available."

AIFA said messenger RNA (mRNA) vaccines should be used "in older and more frail subjects." Such vaccines, which include the Pfizer/BioNTech and Moderna jabs, use an inert snippet of genetic code from COVID-19 to trigger an immune response in the body that repels the active virus.

Swiss regulators said Wednesday that data submitted by AstraZeneca were not sufficient for it to authorise use of the Anglo-Swedish firm's COVID-19 vaccine and "new studies" were needed.

The Swissmedic regulatory authority said it had been examining information from AstraZeneca but that was "not yet sufficient to permit authorisation".

"To obtain more information about safety, efficacy and quality, additional data from new studies are needed," it said in a statement.

Switzerland has so far given the green light to COVID-19 vaccines made by Pfizer-BioNTech and Moderna.

It had been expected to authorise the AstraZeneca jab soon, after the neighbouring European Union last week gave the vaccine the go ahead.

But while the EU granted approval for use in all people over the age of 18, several European countries have advised against giving the jabs to people over 65, citing lack of evidence that it was effective among the elderly.

While UK investors get slaughtered by Rooks , sensible investors continue to rack up 500% + profits in GSK JV with CVAC and VIR, which have grown by over 500% in a year

Makes you weep, or laugh, but there comes a point when the UK is not a lace to invest.

Avatariii
If you are aware, GSK have there own SAM mRNA platform, they just invested in CVAC last July, because they knew CVAC had the most advanced mRNA vaccine , CVAC played the longer game and now it's paying off, as no other vaccine will get near it, apart from BioNtech.

GSK went into a JV with Sanofi and the Efficacy did not meet requirements inover 65's, so they pulled it.
Other less ethical Pharma companys pushed on and the efficacy is not there in older people.

GSK waited and played it 100% right, now they benefit from a vaccine that can be changed in weeks and will cover all variants, something AZN can not do an dwill not do

GlaxoSmithKline (GSK.L, GSK) reported that its fiscal 2020 profit to shareholders increased to 5.75 billion pounds from 4.65 billion pounds, previous year. Earnings per share was 114.1 pence, compared to 92.6 pence

TA

You are so correct.

Watch Doc Martins regret the listing.
I was apprentice in 1972 with Airwair as it was called, pleased to see its return very sad it choose London Hore house to list on

fatsprofits
You are not even on the right page

The mRNA vaccine can be adjusted in a weeks, CVAC Pioneered the technology, that how far behind you are
CVAC and GSK stated in 2019 the technology was advanced , but hye you read your junk

Try looking the real science and data, based on facts

Sorry, but you lack the real knowledge to even know how the mRNA was developed, and when the first mRNA vaccine was actaully produced

fatprofit
ViiV will earn $9 billion per year, yet the city dont want to talk about it,

Its only cut when they split the Consumer health side and investors get free shares in that new company

Idiots abound, GSK is working with the leading Covid vaccine maker in the world

No its not very very rare, this is where real Immunology comes in.

Over 25000 people have been diagnosed with Selective IgMD from vaccines, the UK does not do Immunology, you try and get an appointment with a Immunologist, its only when people have repeated complaints and demand Immunology appointments.

UK Gps cant think outside the box and the UK does not have the number of Immunologist to even diagnose.
A decent Primary Care Physician will pick it up, that is fact and it's why the UK lacks in this area of medicine

Antantar :):) make me laugh, fp changes like the wind, but is till full of wind

And the City missed GSK made $1.9 billion on CVAC and brought another 2 million shares in company for $0.00, from profits on selling 20% of there 10% holding
City is just a backdoor for rooks

DBatrlow, what I said is that AZN did not put out data on over 65's .

Antibodies are not able to found stable in IgG for 3 months,
Also vaccine are know to leave some "people" with what is classed as Selective IgM deficiency, very few people have a IgM test for this, as its classed as rare .

If your sister is having antibody tests for IgG, then hope they check the IgM